Moxquin XG 0.5%+0.4% (Ophthalmic Solution)

Indications

• Treatment of bacterial conjunctivitis caused by susceptible strains of specific organisms
• Indicated for Aerobic Gram-positive and Gram-negative microorganisms

Pharmacology

• Antimicrobial action results from inhibition of topoisomerase II and topoisomerase IV
• DNA gyrase and topoisomerase IV are essential enzymes involved in bacterial DNA replication, transcription, and repair
• Key role in partitioning of chromosomal DNA during bacterial cell division

Dosage & Administration

One drop in the affected eye(s) 2 times daily for 7 days

Interaction

No drug-drug interaction studies conducted

Side Effects

• Frequently reported ocular adverse events
• Ocular adverse events include eye irritation, pyrexia, conjunctivitis, decreased visual acuity, dry eye, ocular discomfort, ocular hyperemia, ocular pain, ocular pruritus, subconjunctival hemorrhage, tearing

Pregnancy & Lactation

Use during pregnancy only if potential benefit justifies potential risk to fetus, caution during lactation

Precautions & Warnings

Prolonged use may result in overgrowth of non-susceptible organisms

Use in Special Populations

• Safety and effectiveness in infants below four months not proven
• May be used safely in children younger than one month
• No overall differences in safety and effectiveness observed between elderly and younger patients

Overdose Effects

Practically no risk of adverse effects due to accidental ingestion

Therapeutic Class

Ophthalmic antibacterial drugs

Storage Conditions

• Store in a cool and dry place away from light
• Keep out of reach of children
• Do not touch the dropper tip to surfaces as it may contaminate the solution
• Do not use the medicine or dropper after one month of the first opening

Related Brands